Eczema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. aged below 18 years old; 2. patients with moderate-to-severe ezcema of SCORAD (SCORing Atopic Dermatitis) scores >15 points; 3. A pruritus frequency of more than 3 days in previous week recorded by Q1 in the POEM questionnaire.
Exclusion criteria
Exclusion criteria: 1. Subjects (patients and parents) have intercurrent illness for two weeks prior to study; 2. Subject with documented allergies to study product components; 3. Subject enrolled in another clinical trial during the study period; 4. Subject/Patient who are unable to read or write in Chinese; 5. Subject/Parent considered by the investigator to be likely not compliant to the protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| eczema severity (SCORAD);modified POEM;CDLQI;PADQLQ; | — |
Secondary
| Measure | Time frame |
|---|---|
| presence of S. aureus at the right antecubital fossae and the most severely infected or eczematous lesions before and following each treatment period;dermatologic parameters (skin hydration, transepidermal water loss, erythema etc.);topical steroid usage;antihistamine usage;patient acceptability of treatment;blood tests as requested by patient(including IgE, eosinophil count, TSLP, NGF etc.);allergic reactions (acute contact dermatitis, urticaria and anaphylaxis);compliance to treatment; | — |
Countries
China
Contacts
The Chinese University of Hong Kong